Jenny Cronin, PhD

Director of Translational Research at the Institute for Protein Design

πŸ“ United StatesπŸ”„ Updated September 2026πŸ’Ό 5 investmentsπŸ“… 5 years investingπŸ—“ Last invested Jan 2022
VC🌍 United States
5
Total investments
5
Early stage
0
Mid stage
0
Late stage
5y
Years active

Portfolio

5 investments Β· sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor / Incubator
2022
CalmWaveβ„’ improves healthcare through data science. Tackling #AlarmFatigue & #NurseRetention with AI-driven insights. #OperationsHealth #StopTheNoise #CalmWave
Board Observer
2021
Modulus is engineering next-generation immune cell therapies, starting with Natural Killer cells rationally designed for the treatment of solid tumors. Modulus’ Convergent Designβ„’ platform combines genetic engineering, machine learning, and high-throughput in vivo screening to systematically converge on optimized cell designs. Modulus is committed to the discovery of cell therapies to treat a broad set of patient populations not currently served by existing treatments and will use its platform to enable partners and develop an internal pipeline of therapeutics.
Investor / Incubator
2021
Reducing Average Handle Time by up to 35% in healthcare, finance and insurance contact centers #NLP #AI
Investor / Incubator
2021
Yoodli is an AI-powered communication enablement platform that helps revenue teams scale roleplay and coachingβ€”giving managers time back, building confident reps faster, and driving pipeline impact. Sales leaders know that confident, prepared reps close more deals. But traditional roleplays and coaching are hard to scale. They consume manager hours, leave gaps in feedback, and slow down onboarding. Yoodli changes the game. With AI-powered roleplay, instant feedback, and scalable coaching insights, reps can practice discovery calls, objection handling, negotiations, and presentations anytime, anywhereβ€”while managers focus on strategy instead of micromanaging. Trusted by Fortune 100 companies including Google, Korn Ferry, Dale Carnegie, and Toastmasters, Yoodli equips sales teams with the confidence and consistency they need to win. Leaders save time, reps ramp faster, and revenue grows. πŸ’‘ Learn more or request a demo: yoodli.ai/contact-sales
Investor / Incubator
2021
MajorBoost uses cutting edge AI to automate phone calls. We handle the hassles, so your team can complete more tasks per day. By bringing data and AI to phone calls, we help teams succeed. Our company was founded by technologists with a passion for solving problems in healthcare and insurance.
Experience Β· 10 entries
All (10)
Investments (5)
Board (1)
2025
Venture Partner
Mar 2025
Pack VC is a pre-seed and seed venture fund supporting and investing in founders associated with the University of Washington (UW) network. We make the venture asset class available to the more than 400,000 global UW alumni.
2022
Investor / Incubator
2022
CalmWaveβ„’ improves healthcare through data science. Tackling #AlarmFatigue & #NurseRetention with AI-driven insights. #OperationsHealth #StopTheNoise #CalmWave
2021
Principal, Startup Incubator
Jun 2021
We are a Seattle-based non-profit AI research institute founded in 2014 by the late Paul Allen. We develop foundational AI research and innovation to deliver real-world impact through large-scale open models, data, robotics, conservation, and beyond.
Principal
Jun 2021
AI House helps founders build AI-first companies through three connected pillars: Community, Incubator, and Capital. β€”β€”β€”β€”β€”β€”β€”β€” π—–π—’π— π— π—¨π—‘π—œπ—§π—¬ gives founders daily access to a dense network of AI founders, researchers, engineers, operators, investors, domain experts, and technical builders working through similar problems in real time. It is where founders meet people who can actually help: potential customers, technical reviewers, resident experts, early investors, future teammates, and peers a few steps ahead. π—œπ—‘π—–π—¨π—•π—”π—§π—’π—₯ is where we work side by side with founders from the earliest stages. Founders can access up to $600K in capital for incubations, $1M+ in free, non-dilutive cloud compute, and hands-on support across idea formation, customer discovery, technical strategy, product decisions, pricing, packaging, positioning, sales, fundraising, recruiting, design, storytelling, and back-office operations. The company remains founder-led. We are not here to run it for you. We are here to be your partner through the messy early work. π—–π—”π—£π—œπ—§π—”π—Ÿ is where we write direct checks of $100K to $1M into applied AI companies built around real customer pain, technical depth, and durable execution. Some are companies we help incubate. Others are founders who already have momentum and just need capital, not incubation. We invest in both Seattle + non-Seattle. β€”β€”β€”β€”β€”β€”β€”β€” π—¦π—˜π—”π—§π—§π—Ÿπ—˜ π—›π—’π— π—˜-π—•π—”π—¦π—˜ We believe Seattle will be one of the most important AI startup ecosystems of the next decade, with world-class technical talent, deep research roots, major cloud infrastructure, experienced operators, and customers across industries where AI will matter most. AI House exists to be the front door for serious AI builders in Seattle and the Pacific Northwest: a place to find co-founders, sharpen ideas, meet customers, access capital, get technical judgment, and build real companies. β€”β€”β€”β€”β€”β€”β€”β€” π—π—’π—œπ—‘ 𝗨𝗦 >> Community. Incubator. Capital. Built for AI founders.
Board Observer
2021
Modulus is engineering next-generation immune cell therapies, starting with Natural Killer cells rationally designed for the treatment of solid tumors. Modulus’ Convergent Designβ„’ platform combines genetic engineering, machine learning, and high-throughput in vivo screening to systematically converge on optimized cell designs. Modulus is committed to the discovery of cell therapies to treat a broad set of patient populations not currently served by existing treatments and will use its platform to enable partners and develop an internal pipeline of therapeutics.
Show all 10 entries ↓
Investment activity
2021–2022 Β· 5 investments
2021420221
Recent (last 2 years)Earlier